Genvec Inc (GNVC) Financial Statements (2024 and earlier)

Company Profile

Business Address 910 CLOPPER ROAD
GAITHERSBURG, MD 20878
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2017
MRQ
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 3,6677,0157,9685,24915,255
Cash and cash equivalents 3,6677,0157,9685,2494,150
Short-term investments     11,105
Receivables 22166325201947
Prepaid expense and other current assets226
Other undisclosed current assets 3,7691,9066,9431,193 
Total current assets: 7,4589,08715,2366,64316,428
Noncurrent Assets
Property, plant and equipment 191279276514805
Restricted cash and investments    97 
Other noncurrent assets 589797 
Prepaid expense and other noncurrent assets197
Total noncurrent assets: 2493763736111,002
TOTAL ASSETS: 7,7079,46315,6097,25417,430
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 1,8471,6942,2221,9532,990
Employee-related liabilities 6844506029051,490
Accounts payable 9571,0961,1461,0481,500
Accrued liabilities 206148474  
Deferred revenue and credits     4
Other undisclosed current liabilities    691693
Total current liabilities: 1,8471,6942,2222,6443,687
Noncurrent Liabilities
Liabilities, other than long-term debt 968989  
Other liabilities 968989  
Other undisclosed noncurrent liabilities 1,059    
Total noncurrent liabilities: 1,1558989  
Total liabilities: 3,0021,7832,3112,6443,687
Equity
Equity, attributable to parent 4,7057,68013,2984,61013,743
Common stock 217171413
Additional paid in capital 295,333292,508291,609280,398279,518
Accumulated other comprehensive loss (3)(5)(33)(22)(27)
Accumulated deficit (290,627)(284,840)(278,295)(275,780)(265,761)
Total equity: 4,7057,68013,2984,61013,743
TOTAL LIABILITIES AND EQUITY: 7,7079,46315,6097,25417,430

Income Statement (P&L) ($ in thousands)

3/31/2017
TTM
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues 5118856,0413,6829,353
Revenue, net 5118856,041  
Gross profit: 5118856,0413,6829,353
Operating expenses (7,726)(7,452)(8,578)(13,976)(23,450)
Operating loss: (7,215)(6,567)(2,537)(10,294)(14,097)
Nonoperating income 1,428   42
Loss from continuing operations: (5,787)(6,567)(2,537)(10,294)(14,055)
Loss before gain (loss) on sale of properties: (5,787)(6,567)(2,537)(10,294)(14,055)
Net loss: (5,787)(6,567)(2,537)(10,294)(14,055)
Other undisclosed net income attributable to parent  2222275 
Net loss available to common stockholders, diluted: (5,787)(6,545)(2,515)(10,019)(14,055)

Comprehensive Income ($ in thousands)

3/31/2017
TTM
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss: (5,787)(6,567)(2,537)(10,294)(14,055)
Comprehensive loss: (5,787)(6,567)(2,537)(10,294)(14,055)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 25011280(19)
Comprehensive loss, net of tax, attributable to parent: (5,785)(6,517)(2,526)(10,014)(14,074)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: